[HTML][HTML] Overcoming cancer therapeutic bottleneck by drug repurposing

Z Zhang, L Zhou, N Xie, EC Nice, T Zhang… - Signal transduction and …, 2020 - nature.com
Ever present hurdles for the discovery of new drugs for cancer therapy have necessitated
the development of the alternative strategy of drug repurposing, the development of old …

[HTML][HTML] The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism

LY Tian, DJ Smit, M Jücker - International Journal of Molecular Sciences, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in
the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains …

[HTML][HTML] mTOR-mediated regulation of immune responses in cancer and tumor microenvironment

S Mafi, B Mansoori, S Taeb, H Sadeghi… - Frontiers in …, 2022 - frontiersin.org
The mechanistic/mammalian target of rapamycin (mTOR) is a downstream mediator in the
phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathways, which plays a pivotal role in …

Charge‐reversal polymer nano‐modulators for photodynamic immunotherapy of cancer

S He, J Li, P Cheng, Z Zeng, C Zhang… - Angewandte Chemie …, 2021 - Wiley Online Library
Nanomedicine can regulate the balance between cytotoxic T lymphocytes (CTLs) and
suppressive regulatory T lymphocytes (Tregs), which however has been rarely exploited for …

[PDF][PDF] Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates

BC Doak, B Over, F Giordanetto, J Kihlberg - Chemistry & biology, 2014 - cell.com
The rule of 5 (Ro5) is a set of in silico guidelines applied to drug discovery to prioritize
compounds with an increased likelihood of high oral absorption. It has been influential in …

Glioblastoma: Current status, emerging targets, and recent advances

A Thakur, C Faujdar, R Sharma, S Sharma… - Journal of Medicinal …, 2022 - ACS Publications
Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …

Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition

N Kong, W Tao, X Ling, J Wang, Y Xiao, S Shi… - Science Translational …, 2019 - science.org
Loss of function in tumor suppressor genes is commonly associated with the
onset/progression of cancer and treatment resistance. The p53 tumor suppressor gene, a …

A systematic review of the global intervention for SARS-CoV-2 combating: from drugs repurposing to molnupiravir approval

NA Ashour, A Abo Elmaaty, AA Sarhan… - Drug design …, 2023 - Taylor & Francis
The rising outbreak of SARS-CoV-2 continues to unfold all over the world. The development
of novel effective antiviral drugs to fight against SARS-CoV-2 is a time cost. As a result, some …

[HTML][HTML] Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies

T Azad, R Rezaei, R Singaravelu, A Pelin… - Nature …, 2023 - nature.com
The large coding potential of vaccinia virus (VV) vectors is a defining feature. However,
limited regulatory switches are available to control viral replication as well as timing and …

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug

Y Li, PK Li, MJ Roberts, RC Arend, RS Samant… - Cancer letters, 2014 - Elsevier
The rapid development of new anticancer drugs that are safe and effective is a common goal
shared by basic scientists, clinicians and patients. The current review discusses one such …